A Smartphone App on Medication Adherence
Study Details
Study Description
Brief Summary
This is an experimental study which aims to explore the effectiveness of a smartphone app for medication adherence (MedAdhere app) among schizophrenic patients for eight weeks.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Schizophrenia is a mental disorder that causes severe functional disabilities and imposes a heavy economic burden. Poor medication adherence is one of the major causes of relapse of psychiatric symptoms in schizophrenic patients. This is an experimental study which aims to explore the effectiveness of a smartphone app for medication adherence (MedAdhere app) among schizophrenic patients for eight weeks.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| control group The control group only received usual care, the PANSS and MMSE were used to assess psychiatric symptoms and cognitive functions before (week 0) and after 8 weeks. |
|
| experimental group The experimental group use the MedAdhere app for eight weeks, the PANSS and MMSE were used to assess psychiatric symptoms and cognitive functions before (week 0) and after (week 8) intervention. |
Behavioral: the MedAdhere app
The experimental group downloaded and used the MedAdhere app on their personal smartphones during this 8-week study
|
Outcome Measures
Primary Outcome Measures
- psychiatric symptoms [Change from Baseline psychiatric symptoms at 8 weeks]
The positive and negative syndrome scale was used to measure participants' psychiatric symptoms. Of the 30 items on the scale, seven are positive symptoms, seven are negative symptoms, and 16 are general psychopathology symptoms. Symptom severity for each item is rated according to the anchoring points in the 7-point scale (1 = absent; 7 = extreme) that best describe the symptom (Kay et al., 1987). The PANSS score is the sum of ratings across items, ranging from 7 to 49 for the Positive, Negative Scales, and 16 to 112 and 16 to 112 for the General Psychopathology Scale.
- cognitive functions [Change from Baseline cognitive functions at 8 weeks]
The Mini-Mental State Examination was used to measure participants' cognitive functions. The MMSE consists of 15 questions for assessing the following seven cognitive domains: orientation in time and place, memory registration and recall, attention and calculation, and language. The total MMSE score ranged from 0 to 30, and higher scores indicate better cognitive functions.
- Medication adherence rate [Change from Baseline Medication adherence' rate at 8 weeks]
Utilizing cloud-based platforms to compute the medication adherence rate.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
schizophrenia
-
aged 20 to 65 years
-
able to read traditional Chinese
-
owning a smartphone
-
currently admitted at a psychiatric day-care center
Exclusion Criteria:
- Intellectually disabled or severe cognitive function impairment (Dementia)
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Kaohsiung Medical University | Kaohsiung | Taiwan | 80708 |
Sponsors and Collaborators
- Kaohsiung Medical University Chung-Ho Memorial Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- KMURCT20200096